Education
About Us
Working with TipRanks
Follow Us
Fresenius Medical Care (FMS)
:FMS
Total Valuation
Fresenius Medical Care has a market cap or net worth of $13.90B. The enterprise value is $27.34B.
Market Cap$13.90B
Enterprise Value$27.34B
Share Statistics
Fresenius Medical Care has 586,826,900 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding586,826,900
Owned by Insiders―
Owned by Institutions0.04%
Financial Efficiency
Fresenius Medical Care’s return on equity (ROE) is 0.04 and return on invested capital (ROIC) is 3.35%.
Return on Equity (ROE)0.04
Return on Assets (ROA)0.02
Return on Invested Capital (ROIC)3.35%
Return on Capital Employed (ROCE)0.05
Revenue Per Employee172.59K
Profits Per Employee6.61K
Employee Count112,035
Asset Turnover0.58
Inventory Turnover7.05
Valuation Ratios
The current PE Ratio of Fresenius Medical Care is 17.4. Fresenius Medical Care’s PEG ratio is 3.12.
PE Ratio17.4
PS Ratio0.66
PB Ratio0.88
Price to Fair Value0.88
Price to FCF7.62
Price to Operating Cash Flow4.42
PEG Ratio3.12
Income Statement
In the last 12 months, Fresenius Medical Care had revenue of 19.34B and earned 537.91M in profits. Earnings per share was 0.92.
Revenue19.34B
Gross Profit4.76B
Operating Income1.39B
Pretax Income1.06B
Net Income537.91M
EBITDA3.21B
Earnings Per Share (EPS)0.92
Cash Flow
In the last 12 months, operating cash flow was 2.51B and capital expenditures -733.05M, giving a free cash flow of 1.78B billion.
Operating Cash Flow2.51B
Free Cash Flow1.78B
Free Cash Flow per Share3.03
Dividends & Yields
Fresenius Medical Care pays an annual dividend of $0.787, resulting in a dividend yield of 3.32%
Dividend Per Share$0.787
Dividend Yield3.32%
Payout Ratio37.27%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.49
52-Week Price Change12.91%
50-Day Moving Average25.94
200-Day Moving Average25.62
Relative Strength Index (RSI)24.79
Average Volume (3m)382.95K
Important Dates
Fresenius Medical Care upcoming earnings date is Feb 24, 2026, TBA (Confirmed).
Last Earnings DateNov 4, 2025
Next Earnings DateFeb 24, 2026
Ex-Dividend DateMay 23, 2025
Financial Position
Fresenius Medical Care as a current ratio of 1.40, with Debt / Equity ratio of 83.07%
Current Ratio1.40
Quick Ratio1.03
Debt to Market Cap0.53
Net Debt to EBITDA3.06
Interest Coverage Ratio3.42
Taxes
In the past 12 months, Fresenius Medical Care has paid 316.06M in taxes.
Income Tax316.06M
Effective Tax Rate0.30
Enterprise Valuation
Fresenius Medical Care EV to EBITDA ratio is 7.07, with an EV/FCF ratio of 13.44.
EV to Sales1.17
EV to EBITDA7.07
EV to Free Cash Flow13.44
EV to Operating Cash Flow9.50
Balance Sheet
Fresenius Medical Care has $1.26B in cash and marketable securities with $10.47B in debt, giving a net cash position of -$9.22B billion.
Cash & Marketable Securities$1.26B
Total Debt$10.47B
Net Cash-$9.22B
Net Cash Per Share-$15.71
Tangible Book Value Per Share-$1.31
Margins
Gross margin is 24.67%, with operating margin of 7.20%, and net profit margin of 2.78%.
Gross Margin24.67%
Operating Margin7.20%
Pretax Margin5.47%
Net Profit Margin2.78%
EBITDA Margin16.58%
EBIT Margin7.57%
Analyst Forecast
The average price target for Fresenius Medical Care is $22.00, which is 11.43% higher than the current price. The consensus rating is Moderate Sell
Price Target$22.00
Price Target Upside-9.43% Downside
Analyst ConsensusModerate Sell
Analyst Count2
Revenue Growth Forecast4.09%
EPS Growth Forecast13.17%